Article The proteogenomic subtypes of acute leukemia

被引:70
作者
Jayavelu, Ashok Kumar [1 ,5 ,6 ,30 ]
Wolf, Sebastian [2 ,27 ]
Buettner, Florian [3 ,4 ,7 ,27 ]
Alexe, Gabriela [8 ,9 ]
Haeupl, Bjoern [2 ,3 ,4 ,27 ]
Comoglio, Federico [10 ]
Schneider, Constanze [2 ]
Doebele, Carmen [2 ,3 ,4 ]
Fuhrmann, Dominik C. [11 ]
Wagner, Sebastian [2 ]
Donato, Elisa [12 ,13 ,14 ]
Andresen, Carolin [12 ,13 ,14 ]
Wilke, Anne C. [2 ]
Zindel, Alena [2 ,3 ,4 ]
Jahn, Dominique [2 ,3 ,4 ]
Splettstoesser, Bianca [1 ]
Plessmann, Uwe [15 ]
Muench, Silvia [2 ]
Abou-El-Ardat, Khali [2 ]
Makowka, Philipp [2 ]
Acker, Fabian [2 ]
Enssle, Julius C. [2 ]
Cremer, Anjali [2 ]
Schnutgen, Frank [2 ,3 ,4 ,27 ]
Kurrle, Nina [2 ,3 ,4 ,27 ]
Chapuy, Bjoern [16 ,28 ]
Loeber, Jens [16 ,28 ]
Hartmann, Sylvia [17 ]
Wild, Peter J. [17 ]
Wittig, Ilka [18 ]
Huebschmann, Daniel [4 ,12 ,13 ,14 ,19 ,20 ]
Kaderali, Lars [21 ]
Cox, Juergen [22 ]
Bruene, Bernhard [11 ]
Roellig, Christoph [23 ]
Thiede, Christian [23 ]
Steffen, Bjoern [2 ]
Bornhaeuser, Martin [23 ,24 ]
Trumpp, Andreas [12 ,13 ,14 ,29 ]
Urlaub, Henning [15 ,25 ]
Stegmaier, Kimberly [8 ,9 ,26 ]
Serve, Hubert [2 ,3 ,4 ,27 ]
Mann, Matthias [1 ]
Oellerich, Thomas [2 ,3 ,4 ,27 ]
机构
[1] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Martinsried, Germany
[2] Univ Hosp Frankfurt, Goethe Univ, Dept Med 2, Hematol Oncol, Theodor Stern Kai 7, Frankfurt, Germany
[3] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, Heidelberg, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
[5] DKFZ, Clin Cooperat Unit Pediat Leukemia, Heidelberg, Germany
[6] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany
[7] Goethe Univ, Univ Hosp Frankfurt, Dept Med, Frankfurt, Germany
[8] Dana Farber Canc Inst, Dept Pediat Oncol, Div Hematol Oncol, Boston, MA 02115 USA
[9] Boston Childrens Hosp, Boston, MA USA
[10] enGene Stat GmbH, Basel, Switzerland
[11] Goethe Univ, Dept Biochem 1, Frankfurt, Germany
[12] German Canc Res Ctr, Div Stem Cells & Canc, Heidelberg, Germany
[13] DKFZ ZMBH Alliance, Heidelberg, Germany
[14] Heidelberg Inst Stem Cell Technol & Expt Med HIST, Heidelberg, Germany
[15] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, Gottingen, Germany
[16] Univ Med Ctr Gottingen, Dept Med Hematol & Oncol, Gottingen, Germany
[17] Univ Hosp Frankfurt, Dr Senckenberg Inst Pathol, Frankfurt, Germany
[18] Goethe Univ, Inst Cardiovasc Physiol, Funct Prote, Frankfurt, Germany
[19] Heidelberg Inst Stem Cell Technol & Expt Med HIST, Pattern Recognit & Digital Med, Heidelberg, Germany
[20] Natl Ctr Tumor Dis NCT Heidelberg, Mol Precis Oncol Program, Computat Oncol, Heidelberg, Germany
[21] Univ Med Greifswald, Inst Bioinformat, Greifswald, Germany
[22] Max Planck Inst Biochem, Computat Syst Biochem Res Grp, Martinsried, Germany
[23] Univ Hosp Carl Gustav Carus TU Dresden, Dept Internal Med 1, Dresden, Germany
[24] Dresden NCT UCC, Natl Ctr Tumor Dis, Dresden, Germany
[25] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt, Gottingen, Germany
[26] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[27] Goethe Univ Frankfurt, Frankfurt Canc Inst, Frankfurt, Germany
[28] Univ Med Berlin, Charite, Dept Hematol Oncol & Tumor Immunol, Campus Benjamin Franklin, Berlin, Germany
[29] German Canc Consortium DKTK, Heidelberg, Germany
[30] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany
关键词
ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; FUNCTIONAL PREDICTIONS; COMPUTATIONAL PLATFORM; DATABASE; PROTEIN; HETEROGENEITY; AML; CLASSIFICATION; IDENTIFICATION;
D O I
10.1016/j.ccell.2022.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a comprehensive proteogenomic analysis of bone marrow biopsies from 252 uniformly treated AML patients to elucidate the molecular pathophysiology of AML in order to inform future diagnostic and therapeutic approaches. In addition to in-depth quantitative proteomics, our analysis includes cytogenetic profiling and DNA/RNA sequencing. We identify five proteomic AML subtypes, each reflecting specific biological features spanning genomic boundaries. Two of these proteomic subtypes correlate with patient outcome, but none is exclusively associated with specific genomic aberrations. Remarkably, one subtype (Mito-AML), which is captured only in the proteome, is characterized by high expression of mitochondrial proteins and confers poor outcome, with reduced remission rate and shorter overall survival on treatment with intensive induction chemotherapy. Functional analyses reveal that Mito-AML is metabolically wired toward stronger complex I-dependent respiration and is more responsive to treatment with the BCL2 inhibitor venetoclax.
引用
收藏
页码:301 / +
页数:30
相关论文
共 97 条
  • [1] Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets
    Argelaguet, Ricard
    Velten, Britta
    Arnol, Damien
    Dietrich, Sascha
    Zenz, Thorsten
    Marioni, John C.
    Buettner, Florian
    Huber, Wolfgang
    Stegle, Oliver
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2018, 14 (06)
  • [2] MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
    Armstrong, SA
    Staunton, JE
    Silverman, LB
    Pieters, R
    de Boer, ML
    Minden, MD
    Sallan, SE
    Lander, ES
    Golub, TR
    Korsmeyer, SJ
    [J]. NATURE GENETICS, 2002, 30 (01) : 41 - 47
  • [3] Gene Ontology: tool for the unification of biology
    Ashburner, M
    Ball, CA
    Blake, JA
    Botstein, D
    Butler, H
    Cherry, JM
    Davis, AP
    Dolinski, K
    Dwight, SS
    Eppig, JT
    Harris, MA
    Hill, DP
    Issel-Tarver, L
    Kasarskis, A
    Lewis, S
    Matese, JC
    Richardson, JE
    Ringwald, M
    Rubin, GM
    Sherlock, G
    [J]. NATURE GENETICS, 2000, 25 (01) : 25 - 29
  • [4] Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
    Baccelli, Irene
    Gareau, Yves
    Lehnertz, Bernhard
    Gingras, Stephane
    Spinella, Jean-Francois
    Corneau, Sophie
    Mayotte, Nadine
    Girard, Simon
    Frechette, Melanie
    Blouin-Chagnon, Valerie
    Leveille, Koryne
    Boivin, Isabel
    MacRae, Tara
    Krosl, Jana
    Thiollier, Clarisse
    Lavallee, Vincent-Philippe
    Kanshin, Evgeny
    Bertomeu, Thierry
    Coulombe-Huntington, Jasmin
    St-Denis, Corinne
    Bordeleau, Marie-Eve
    Boucher, Genevieve
    Roux, Philippe P.
    Lemieux, Sebastien
    Tyers, Mike
    Thibault, Pierre
    Hebert, Josee
    Marinier, Anne
    Sauvageau, Guy
    [J]. CANCER CELL, 2019, 36 (01) : 84 - +
  • [5] Dimensionality reduction for visualizing single-cell data using UMAP
    Becht, Etienne
    McInnes, Leland
    Healy, John
    Dutertre, Charles-Antoine
    Kwok, Immanuel W. H.
    Ng, Lai Guan
    Ginhoux, Florent
    Newell, Evan W.
    [J]. NATURE BIOTECHNOLOGY, 2019, 37 (01) : 38 - +
  • [6] Targeting Epigenetic Programs in MLL-Rearranged Leukemias
    Bernt, Kathrin M.
    Armstrong, Scott A.
    [J]. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 354 - 360
  • [7] Bhatt S., 2020, REDUCED MITOCHONDRIA
  • [8] The role of Smad signaling in hematopoiesis and translational hematology
    Blank, U.
    Karlsson, S.
    [J]. LEUKEMIA, 2011, 25 (09) : 1379 - 1388
  • [9] Smad7 promotes self-renewal of hematopoietic stem cells
    Blank, Ulrika
    Karlsson, Goran
    Moody, Jennifer L.
    Utsugisawa, Taiju
    Magnusson, Mattias
    Singbrant, Sofie
    Larsson, Jonas
    Karlsson, Stefan
    [J]. BLOOD, 2006, 108 (13) : 4246 - 4254
  • [10] Gene essentiality and synthetic lethality in haploid human cells
    Blomen, Vincent A.
    Majek, Peter
    Jae, Lucas T.
    Bigenzahn, Johannes W.
    Nieuwenhuis, Joppe
    Staring, Jacqueline
    Sacco, Roberto
    van Diemen, Ferdy R.
    Olk, Nadine
    Stukalov, Alexey
    Marceau, Caleb
    Janssen, Hans
    Carette, Jan E.
    Bennett, Keiryn L.
    Colinge, Jacques
    Superti-Furga, Giulio
    Brummelkamp, Thijn R.
    [J]. SCIENCE, 2015, 350 (6264) : 1092 - 1096